Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EVE Health GroupASX:EVE Return-on-Tangible-Asset is -154.04% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 1,995 Consumer Packaged Goods companies, EVE Health Group ranks worse than 98.15% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. EVE Health Group's annualizedNet Income for the quarter that ended in Dec. 2025 was A$-1.70 Mil. EVE Health Group's average total tangible assets for the quarter that ended in Dec. 2025 was A$1.10 Mil. Therefore, EVE Health Group's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was -154.04%.
The historical rank and industry rank for EVE Health Group's Return-on-Tangible-Asset or its related term are showing as below:
ASX:EVE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -156.47 Med: -41.32 Max: -18.95
Current: -156.47
During the past 13 years, EVE Health Group's highest Return-on-Tangible-Asset was -18.95%. The lowest was -156.47%. And the median was -41.32%.
ASX:EVE's Return-on-Tangible-Asset is ranked worse than 98.15% of 1995
companies
in the Consumer Packaged Goods industry
Industry Median: 3.41
vs ASX:EVE: -156.47
EVE Health Group (ASX:EVE) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
EVE Health Group Return-on-Tangible-Asset Related Terms
EVE Health Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for EVE Health Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EVE vs KHC, GIS: Return-on-Tangible-Asset Comparison
For the Packaged Foods subindustry, EVE Health Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group Return-on-Tangible-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where EVE Health Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of -154.04% mean?
EVE Health Group (ASX:EVE) has a Return-on-Tangible-Asset of -154.04% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #1958 out of 1995 companies in the Consumer Packaged Goods industry, placing it in the top 98.1%.
Is EVE Health Group's Return-on-Tangible-Asset too high?
EVE Health Group's current Return-on-Tangible-Asset is -154.04%. Based on the distribution chart, EVE Health Group ranks #1958 out of 1995 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's Return-on-Tangible-Asset compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #1958 out of 1995 companies for Return-on-Tangible-Asset. This places EVE Health Group in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.41, based on 1,995 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current Return-on-Tangible-Asset is -154.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current Return-on-Tangible-Asset is -154.04%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current Return-on-Tangible-Asset is -154.04% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 
